Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Jan 5;4(2):259–269. doi: 10.1158/1940-6207.CAPR-10-0215

Figure 4.

Figure 4

Change in apoptosis (caspase-3), by intervention arm. Based on biopsy samples from normal-appearing rectal mucosa obtained during the pre-intervention (baseline) and post-intervention evaluations. Box and whisker plot, demonstrating median, interquartile range, and extreme values; mean value also represented (+). Arm A: atorvastatin 20 mg tablet once per day; Arm B: sulindac 150 mg tablet twice per day; Arm C: ORAFTI®Synergy1 6 gm powder twice per day; Arm D: control (maltodextrin powder) twice per day.